0001138723-20-000113.txt : 20201202
0001138723-20-000113.hdr.sgml : 20201202
20201202214153
ACCESSION NUMBER: 0001138723-20-000113
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201130
FILED AS OF DATE: 20201202
DATE AS OF CHANGE: 20201202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEVINE JOSHUA
CENTRAL INDEX KEY: 0001159917
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33301
FILM NUMBER: 201365541
MAIL ADDRESS:
STREET 1: 1310 CHESAPEAKE TERRACE
CITY: SUNNYVALE
STATE: CA
ZIP: 94089
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACCURAY INC
CENTRAL INDEX KEY: 0001138723
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 208370041
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 1310 CHESAPEAKE TERRACE
CITY: SUNNYVALE
STATE: CA
ZIP: 94089
BUSINESS PHONE: 4087164600
MAIL ADDRESS:
STREET 1: 1310 CHESAPEAKE TERRACE
CITY: SUNNYVALE
STATE: CA
ZIP: 94089
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-11-30
0
0001138723
ACCURAY INC
ARAY
0001159917
LEVINE JOSHUA
1310 CHESAPEAKE TERRACE
SUNNYVALE
CA
94089
1
1
0
0
President & CEO
Common Stock
2020-11-30
4
A
0
280269
0.0
A
1045212
D
Common Stock
2020-12-02
4
S
0
15674
4.0707
D
1029538
D
Non-Qualified Stock Option (right to buy)
4.46
2020-11-30
4
A
0
527426
0.0
A
2030-11-30
Common Stock
527426
527426
D
Fiscal year 2021 Performance award with two Performance Measurement Periods The first represents 40% of the grant and is from 7/1/2020 to 6/30/2021. The second represents 60% and is from 7/1/2021 to 06/30/2022. If the metrics are met for the first performance period vesting will commence quarterly beginning 9/30/2021 and ending 06/30/2023. If the metrics are met for the second performance period vesting will commence quarterly beginning 09/30/2022 and ending 06/30/2023.
Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States.
25% of the shares subject to such Option shall vest and be exercisable on the one-year anniversary of the Grant Date and an additional 1/48th of the original number of shares subject to such Option shall vest on the corresponding date of each month thereafter, subject to the applicable Grantee continuing to be a service provider through each such date.
By: Brandy Green For: Joshua Levine
2020-12-02